Presenting at Antibody Engineering & Therapeutics

2022/11/10

Our Senior Director, Norio Hamamatsu will be presenting at the biggest Antibody engineering conference, Antibody Engineering & Therapeutics on December 4 - 8, 2022.

https://informaconnect.com/antibody-engineering-therapeutics/speakers/norio-hamamatsu-phd/

RevolKa expanding research projects with Daiichi Sankyo

RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs

RevolKa Started joint research of a drug discovery program for rare diseases

Related Articles